In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury.

医学 危险系数 急性肾损伤 置信区间 回顾性队列研究 肾脏疾病 比例危险模型 内科学 队列 急诊医学 肌酐 队列研究
作者
Ryann Sohaney,Huiying Yin,Vahakn Shahinian,Rajiv Saran,Nilka Ríos Burrows,Meda E Pavkov,Tanushree Banerjee,Chi-yuan Hsu,Neil Powe,Diane Steffick,Kara Zivin,Michael Heung
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:17 (2): 184-193
标识
DOI:10.2215/cjn.01730221
摘要

AKI, a frequent complication among hospitalized patients, confers excess short- and long-term mortality. We sought to determine trends in in-hospital and 1-year mortality associated with AKI as defined by Kidney Disease Improving Global Outcomes consensus criteria.This retrospective cohort study used data from the national Veterans Health Administration on all patients hospitalized from October 1, 2008 to September 31, 2017. AKI was defined by Kidney Disease Improving Global Outcomes serum creatinine criteria. In-hospital and 1-year mortality trends were analyzed in patients with and without AKI using Cox regression with year as a continuous variable.We identified 1,688,457 patients and 2,689,093 hospitalizations across the study period. Among patients with AKI, 6% died in hospital, and 28% died within 1 year. In contrast, in-hospital and 1-year mortality rates were 0.8% and 14%, respectively, among non-AKI hospitalizations. During the study period, there was a slight decline in crude in-hospital AKI-associated mortality (hazard ratio, 0.98 per year; 95% confidence interval, 0.98 to 0.99) that was attenuated after accounting for patient demographics, comorbid conditions, and acute hospitalization characteristics (adjusted hazard ratio, 0.99 per year; 95% confidence interval, 0.99 to 1.00). This stable temporal trend in mortality persisted at 1 year (adjusted hazard ratio, 1.00 per year; 95% confidence interval, 0.99 to 1.00).AKI associated mortality remains high, as greater than one in four patients with AKI died within 1 year of hospitalization. Over the past decade, there seems to have been no significant progress toward improving in-hospital or long-term AKI survivorship.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
慕青应助佳节采纳,获得10
刚刚
George完成签到,获得积分10
3秒前
合适研发看完成签到,获得积分10
4秒前
发论文发布了新的文献求助10
4秒前
6秒前
大个应助西咪采纳,获得10
7秒前
陈泽冉完成签到,获得积分20
8秒前
义气过客完成签到,获得积分10
9秒前
10秒前
13秒前
量子星尘发布了新的文献求助10
16秒前
JamesPei应助紧张的乐蕊采纳,获得10
18秒前
从容道罡完成签到,获得积分10
18秒前
liran12319发布了新的文献求助10
19秒前
Pangolin完成签到,获得积分10
19秒前
19秒前
21秒前
水瓶完成签到,获得积分10
22秒前
小李子完成签到,获得积分10
23秒前
24秒前
青耕完成签到,获得积分10
24秒前
Young4399完成签到 ,获得积分10
26秒前
小小牛马发布了新的文献求助10
27秒前
所所应助唠叨的剑通采纳,获得10
28秒前
锋回露转123完成签到,获得积分10
28秒前
帕尼灬尼发布了新的文献求助30
29秒前
29秒前
林药师完成签到 ,获得积分10
31秒前
张三完成签到,获得积分10
33秒前
33秒前
星辰大海应助liran12319采纳,获得10
34秒前
山长子完成签到,获得积分10
34秒前
白石杏完成签到,获得积分10
35秒前
情怀应助人间理想采纳,获得20
36秒前
VitoLi发布了新的文献求助10
36秒前
科研通AI6.1应助王世俊采纳,获得10
40秒前
42秒前
43秒前
快快乐乐巴完成签到,获得积分10
43秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Cronologia da história de Macau 1600
Developmental Peace: Theorizing China’s Approach to International Peacebuilding 1000
Traitements Prothétiques et Implantaires de l'Édenté total 2.0 1000
Earth System Geophysics 1000
Bioseparations Science and Engineering Third Edition 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6131541
求助须知:如何正确求助?哪些是违规求助? 7959022
关于积分的说明 16515685
捐赠科研通 5248775
什么是DOI,文献DOI怎么找? 2803033
邀请新用户注册赠送积分活动 1784035
关于科研通互助平台的介绍 1655139